Table 1.
Patients characteristics (n = 83).
| Age (years) | |
| Mean ± SD | 56.2 ± 12.1 |
| Median | 55 |
| Range | 27–80 |
| WHO* performance status, no. | |
| 0 | 59 |
| 1 | 14 |
| >2 | 0 |
| FIGO** surgical stage, no. | |
| Ia | 32 |
| Ib | 43 |
| Ic | 3 |
| IIIa | 5 |
| Adjuvant chemotherapy, no. | |
| None | 74 |
| Paclitaxel/carboplatin§ | 9 |
| Follow up interval (months) | |
| Median (range) | 72 (4–120) |
WHO*: World Health Organization, FIGO**: International Federation of Gynecology and Obstetrics Paclitaxel/carboplatin §: Paclitaxel (180 mg/m2) and carboplatin (area under the curve; AUC 5).